Citius Pharmaceuticals Inc (NASDAQ:CTXR)
| 0.6781 Delayed Data As of 3:58pm ET |  +0.0254 / +3.89%Today’s Change | 0.63 Today|||52-Week Range 1.71 | -14.16% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $108.7M |
Company Description
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
Contact Information
Citius Pharmaceuticals, Inc. 11 Commerce Drive Cranford New Jersey 07016 |
Employees
Shareholders
| Mutual fund holders | 9.74% |
| Individual stakeholders | 7.75% |
| Other institutional | 6.20% |
Top Executives
| Leonard L. Mazur | Chairman, Chief Executive Officer & Secretary |
| Gary F. Talarico | Executive Vice President-Operations |
| Jaime Bartushak | Chief Financial & Business Officer |
| Alan Lader | SVP, Head-Clinical Operations & Quality Assurance |
| Myron S. Czuczman | Chief Medical Officer & Executive Vice President |
